Posted by Jack Khan > 2 months ago | Report Abuse

Posted by gsooi100 > 15 hours ago | Report Abuse
should be rm 0.016 to be exact.

If can rm80, means dividen sure have 0.01 cent per quarter. So,at least the price should stand rm0.70. Should b no wrong gua.. 🤔🤔

Posted by kai8994 > 2 months ago | Report Abuse

Yes, it’s very likely that it’s 1 cent or more per quarter this year. This is slightly more than a 6% dividend yield at the current price. Coupled with the growing total addressable market, it’s definitely worth holding for the long term.

Posted by gsooi100 > 2 months ago | Report Abuse

Hope coming quarter result got rm80m.. divided more than 1 cent.. ☺️☺️☺️

Posted by chemistry > 2 months ago | Report Abuse

profit 80mil is a sure thing. But the market seem unwilling to give it a fair price (fair PE). Nowadays the hot topic is DATA CENTRE. If the company takes any action related to the data center at this time, it will definitely attract market attention. LOL

Posted by Plantermen > 2 months ago | Report Abuse

Yes. DC is the buzz word. Market looking positively at DC related stocks. Others relegated to side show

Posted by gsooi100 > 2 months ago | Report Abuse

I believe coming result will 👍.. hold tight

Posted by gsooi100 > 2 months ago | Report Abuse

Good result.. hope the price can stand above 700…

Posted by Jack Khan > 2 months ago | Report Abuse

every quarter revenue and profit up! ++ Dividend every quater

Posted by Joel77 > 2 months ago | Report Abuse

Why shares prices not moving even good quarter result?

Posted by gsooi100 > 2 months ago | Report Abuse

Haha… good question. Maybe coming AGM can ask boss…

Posted by Investor128 > 2 months ago | Report Abuse

Don’t push yet. I am still trying to gather at low price

Posted by LuckyWinForever > 1 month ago | Report Abuse

This one wont go up punya lah. So cheap 😕

Posted by Good123 > 3 weeks ago | Report Abuse

Buy, dividend ~6%

DXN Holdings 1Q net profit up 10.26%, targets market presence in Zambia, Ghana

Posted by Good123 > 3 weeks ago | Report Abuse

Post-briefing update
Sales momentum in the majority of DXN’s operating regions have performed well in 1QFY25 but the surge in DXN’s core raw material costs will eventually weigh on group margins as product price adjustments may not fully offset higher production costs. We lower our FY25E-FY27E earnings estimate by 5%-8%. Rolling forward valuations to CY25E, our TP is lowered to MYR0.85 based on an unchanged 11x PER. Maintain BUY.

Posted by Good123 > 3 weeks ago | Report Abuse

Ipo price 70sen, Mbb target 85sen

Posted by Good123 > 3 weeks ago | Report Abuse

Dividend yield5.9%~6%

Posted by Good123 > 3 weeks ago | Report Abuse

DXN Holdings Berhad is a Malaysian company that primarily operates in the health and wellness sector. It is known for its production of dietary supplements, food and beverages, personal care products, and household items, with a focus on Ganoderma-based products.

In terms of potential, DXN Holdings has several factors in its favor:

1. **Global Reach**: DXN operates in over 180 countries with a large network of independent distributors. This wide global footprint provides a strong base for growth, especially in emerging markets where health and wellness trends are increasing.

2. **Growing Health and Wellness Market**: The global demand for supplements, particularly those promoting natural health benefits, is on the rise. DXN's core product offerings align with consumer trends favoring organic and herbal supplements.

3. **Multi-level Marketing Model**: DXN uses a direct selling approach through a multi-level marketing (MLM) model. While MLM has risks and is highly regulated, DXN has sustained a large base of distributors, which supports consistent revenue generation.

4. **Product Diversification**: Beyond supplements, DXN has diversified into other product categories like food, beverages, cosmetics, and personal care. This reduces reliance on any single product and opens opportunities in various sectors.

5. **Sustainability Focus**: DXN’s focus on natural and organic products positions it well in markets that value sustainability and eco-friendly consumption.

Overall, DXN’s strong brand, global presence, and product diversification offer significant growth potential, particularly if it capitalizes on the increasing demand for wellness products.

Posted by Good123 > 3 weeks ago | Report Abuse

DXN Holdings Berhad was founded by **Datuk Dr. Lim Siow Jin** in 1993. He is a renowned figure in the wellness industry, especially for his pioneering work with **Ganoderma**, a type of mushroom that is believed to have various health benefits. Dr. Lim's background in holistic health and his passion for natural remedies drove him to establish DXN, focusing on products that promote overall wellness.

Dr. Lim is also well-regarded for his vision of combining the principles of traditional medicine with modern scientific research, particularly in the cultivation and commercialization of Ganoderma. Under his leadership, DXN has grown into a global network, with a presence in over 180 countries, making it one of the prominent names in the direct-selling wellness industry.

His leadership and vision continue to play a significant role in DXN's success and global expansion.

Posted by Good123 > 3 weeks ago | Report Abuse

Datuk Dr. Lim Siow Jin, the founder of DXN Holdings, holds a degree in **Engineering** from the **Indian Institute of Technology (IIT), Bombay**. Despite his engineering background, he became deeply interested in traditional medicine, particularly in the health benefits of **Ganoderma** (also known as Lingzhi or Reishi mushrooms), which led him to establish DXN.

Dr. Lim also pursued further studies and research in holistic health and traditional herbal medicine, which played a crucial role in the development of DXN's products. His scientific approach, combined with a passion for natural wellness, has been a key factor in DXN's success in promoting Ganoderma-based health solutions globally.

Posted by Good123 > 3 weeks ago | Report Abuse

DXN, a Malaysian-based company, is a global network marketing (MLM) enterprise primarily known for its cultivation, manufacture, and distribution of health and wellness products. Here are some key reasons why DXN might be of interest:

1. **Ganoderma Expertise**: DXN is renowned for its use of **Ganoderma** (a type of mushroom known for its medicinal properties) in its health products. It’s a pioneer in cultivating and marketing this product, which is central to their offerings, particularly in supplements, teas, coffees, and skincare.

2. **Global Reach**: DXN operates in over 180 countries and has a large distributor base. Its global footprint has made it one of the largest MLM companies in Asia, and it has expanded rapidly in regions like Latin America, Africa, and the Middle East.

3. **Network Marketing Model**: As an MLM company, DXN provides opportunities for people to become distributors and earn income through sales and recruitment. This business model has attracted a wide range of individuals looking for entrepreneurial opportunities, especially in developing countries.

4. **Health and Wellness Focus**: DXN’s products cater to the growing global trend of health-conscious consumers, focusing on herbal-based supplements, organic products, and natural remedies. This sector has seen a steady rise, making DXN's offerings more relevant.

5. **Vertical Integration**: DXN controls the entire production process, from farming to manufacturing to distribution. This vertical integration ensures product quality and gives the company better control over costs and supply chains.

6. **Stock Market Listing**: DXN went public and is listed on the Malaysian stock exchange (Bursa Malaysia). It is a point of interest for investors due to its global reach and profitability.

7. **Sustainability & Agriculture**: DXN has been involved in sustainable agricultural practices, especially in the cultivation of Ganoderma, and they emphasize organic farming in their production process.

8. **Resilience in the Market**: The company has maintained steady growth even during challenging economic periods due to its global reach, diverse product range, and growing health-conscious customer base.

These factors contribute to why DXN is often discussed in business, wellness, and investment circles.

Posted by Good123 > 3 weeks ago | Report Abuse

Last Price

0.615

Avg Target Price

0.89

Upside/Downside

+0.275 (44.72%)

https://klse.i3investor.com/web/stock/analysis-price-target/5318

Posted by simonS > 3 weeks ago | Report Abuse

very low-profile money-making company, will steady dividend worth while to invest.

Posted by Joel77 > 2 weeks ago | Report Abuse

sudden big volume throwing now, something happen soon?

Posted by Good123 > 2 weeks ago | Report Abuse

just grab from contra players hehe... buy cheaply from margin players... once in a lifetime yah hehe

Posted by Good123 > 2 weeks ago | Report Abuse

Direct deal

History
Date Price Change Dir-Volume Day Volume Dir-Value Day Value Avg Price % of Total Share Remarks
15/01/2024 00:00:00 0.6900 -0.0050 36.200m 36.200m 24.978m 24.978m 0.6900 0.7262 -
09/01/2024 00:00:00 0.6950 -0.0050 35.900m 35.900m 24.951m 24.951m 0.6950 0.7202 -
07/08/2023 00:00:00 0.7000 -0.0250 65,790 65,790 46,053 46,053 0.7000 0.0013 -
23/06/2023 00:00:00 0.7000 0.0400 1.000m 1.000m 700,000 700,000 0.7000 0.0201 -
19/05/2023 00:00:00 0.7350 0.0350 1.500m 1.500m 1.103m 1.103m 0.7350 0.0301 -
Summary from 19/05/2023 to 15/01/2024
Highest Price 0.7350 First Occurred on 19/05/2023
Lowest Price 0.6900 First Occurred on 15/01/2024
Highest Volume 36.200m First Occurred on 15/01/2024

Posted by Good123 > 2 weeks ago | Report Abuse

above 60sen etc anytime.. hehe

Posted by stevenckheng > 2 weeks ago | Report Abuse

wow this one dnex?

Posted by aklobi > 2 weeks ago | Report Abuse

Bought @0.60

Posted by Good123 > 2 weeks ago | Report Abuse

DXN did very well in:

Broadening the Products/Markets The future survival and success of a Company hinges on its products and markets.
Under today's highly competitive business environment, there is no guarantee that a
company possessing a very successful product in a very lucrative market will continue to
enjoy such success. Competitors will always try to introduce competing or alternative
products with enhanced performance at greatly reduced price (products and market
strategy). To broaden the product/market base. For example, several successful products
operating in many markets is actually building a strong defence invulnerable to attack.


Building Up Resilience to Recessionary Conditions To build up its resilience against the recessionary pressure. For example, a Company with
a proactive management can expect and sense the approaching of a recession, and work
out strategies in terms of its product/market mix well in advance to reduce the adverse
impact of recession. Moreover, the management may also take some precautionary
measures to make the Company lean, in a stronger position to face the downturn.

Posted by Good123 > 2 weeks ago | Report Abuse

c u at 85sen as per MBB target price hurray.. rebounding confidently now hehe

Posted by Good123 > 2 weeks ago | Report Abuse

All in...
Maybank's target price for DXN Holdings Berhad at 85 sen likely reflects an in-depth analysis of the company's financials, market position, and industry trends. Let’s dive into the exciting details behind this target price!

### **1. **Financial Performance:**
- **Revenue and Profit Growth**: DXN’s recent financial reports might show robust revenue and profit growth, especially in the direct selling industry. Analysts like Maybank would closely evaluate these figures to project future earnings.
- **Earnings Per Share (EPS)**: A strong EPS growth trend could be a key factor in setting the target price. If DXN is delivering impressive EPS figures, it would positively influence Maybank’s valuation.

### **2. **Market Position and Competitive Advantage:**
- **Strong Brand Presence**: DXN, known for its direct selling of health and wellness products, has established a strong brand presence. This competitive advantage can lead to higher market share and better financial performance.
- **Product Line and Innovation**: The company’s diverse and innovative product line, including its flagship Ganoderma-based products, could be contributing to its growth. If DXN is seen as a leader in product innovation, it enhances its investment appeal.

### **3. **Industry Trends:**
- **Growth in Health & Wellness**: The health and wellness industry is experiencing significant growth. If DXN is well-positioned to capitalize on this trend, it could drive higher revenues and profits.
- **Direct Selling Dynamics**: The direct selling model can be highly profitable with lower overhead costs. Analysts might view DXN’s efficiency in this model as a positive factor for future performance.

### **4. **Valuation Metrics:**
- **Discounted Cash Flow (DCF) Analysis**: Maybank might use DCF analysis to estimate the present value of DXN’s future cash flows. A target price of 85 sen could be derived from this valuation method, reflecting the company’s potential to generate future cash flow.
- **Price-to-Earnings (P/E) Ratio**: Comparing DXN’s P/E ratio with industry peers might show it is undervalued or fairly valued at 85 sen. This metric helps analysts gauge whether the stock price aligns with earnings expectations.

### **5. **Market Sentiment and External Factors:**
- **Regulatory Environment**: Positive or stable regulatory conditions for direct selling companies in Malaysia can support a higher target price.
- **Economic Conditions**: Favorable economic conditions and consumer spending trends in Malaysia and other markets where DXN operates could boost its stock price expectations.

### **6. **Strategic Initiatives and Expansion Plans:**
- **New Markets and Products**: DXN’s plans to enter new markets or launch new products can create excitement about its growth prospects. If Maybank sees these initiatives as promising, it could positively impact the target price.
- **Partnerships and Alliances**: Strategic partnerships or alliances that enhance DXN’s market position could be factored into the target price.

### **Excitement Behind the Target Price!**
Imagine DXN as a dynamic company riding the wave of booming health and wellness trends. With a solid financial performance, a winning direct selling model, and exciting product innovations, DXN is like a rocket on the launch pad, ready to soar to new heights. Maybank’s target price of 85 sen reflects their confidence in DXN’s potential to achieve great things and deliver solid returns for investors!

So, if you’re watching DXN, think of it as a thrilling opportunity in a high-growth sector, with plenty of excitement on the horizon! 🚀📈

Posted by Good123 > 2 weeks ago | Report Abuse

uptrend restarts anytime... fun time

Posted by Good123 > 2 weeks ago | Report Abuse

buy more

DATUK LIM SIOW JIN 09-Jan-2024 Others 80,000,000 0.625
DATUK LIM SIOW JIN 30-Nov-2023 Acquired 345,000 0.651
DATUK LIM SIOW JIN 29-Nov-2023 Acquired 219,600 0.660
DATUK LIM SIOW JIN 28-Nov-2023 Acquired 132,100 0.666
DATUK LIM SIOW JIN 27-Nov-2023 Acquired 98,000 0.663
DATUK LIM SIOW JIN 24-Nov-2023 Acquired 292,300 0.668
DATUK LIM SIOW JIN 23-Nov-2023 Acquired 91,000 0.672
DATUK LIM SIOW JIN 22-Nov-2023 Acquired 133,600 0.659
DATUK LIM SIOW JIN 22-Sep-2023 Acquired 769,100 0.689
DATUK LIM SIOW JIN 21-Sep-2023 Acquired 169,700 0.690
DATUK LIM SIOW JIN 18-Sep-2023 Acquired 115,000 0.699
DATUK LIM SIOW JIN 15-Sep-2023 Acquired 190,600 0.700
DATUK LIM SIOW JIN 14-Sep-2023 Acquired 90,000 0.704
DATUK LIM SIOW JIN 13-Sep-2023 Acquired 684,600 0.699
DATUK LIM SIOW JIN 12-Sep-2023 Acquired 1,863,900 0.694
DATUK LIM SIOW JIN 11-Sep-2023 Acquired 60,000 0.685
MISS ONG HUEY MIN 07-Sep-2023 Acquired 20,000 0.705
MISS ONG HUEY MIN 06-Sep-2023 Acquired 25,000 0.700
MISS ONG HUEY MIN 05-Sep-2023 Acquired 25,000 0.695
MISS ONG HUEY MIN 30-May-2023 Acquired 20,000 0.650
MISS ONG HUEY MIN 29-May-2023 Acquired 10,000 0.655
MISS ONG HUEY MIN 26-May-2023 Acquired 20,000 0.645
MR TEOH HANG CHING 18-May-2023 Others 830,000 0.700
MR TEOH HANG CHING 18-May-2023 Others 39,000 0.700
MR TEOH HANG CHING 18-May-2023 Others 36,000

Posted by Good123 > 2 weeks ago | Report Abuse

share buyback, anytime? hehe


From To Type No. of Shares Min Price Max Price
28-Feb-2024 28-Feb-2024 Buyback 1,694,100 0.630 0.630
27-Feb-2024 27-Feb-2024 Buyback 2,242,600 0.630 0.630
26-Feb-2024 26-Feb-2024 Buyback 4,437,800 0.630 0.635
23-Feb-2024 23-Feb-2024 Buyback 1,660,000 0.635 0.640
22-Feb-2024 22-Feb-2024 Buyback 746,800 0.640 0.640
22-Feb-2024 28-Feb-2024 Buyback 10,781,300 0.630 0.640
02-Nov-2023 02-Nov-2023 Buyback 30,000 0.665 0.675
01-Nov-2023 01-Nov-2023 Buyback 200,000 0.660 0.665
31-Oct-2023 31-Oct-2023 Buyback 189,000 0.655 0.675
30-Oct-2023 30-Oct-2023 Buyback 670,200 0.660 0.680
27-Oct-2023 27-Oct-2023 Buyback 190,000 0.670 0.685
26-Oct-2023 26-Oct-2023 Buyback 178,000 0.660 0.675
26-Oct-2023 02-Nov-2023 Buyback 1,457,200 0.655 0.685

Posted by Good123 > 2 weeks ago | Report Abuse

DXN's shares appear to be undervalued for several reasons. First, its reliance on the multi-level marketing (MLM) model, while profitable, carries a higher level of regulatory risk and market perception challenges. MLMs are often viewed with skepticism, which can deter some investors from the stock. Additionally, despite its global presence and product diversification in wellness and organic products, the company may face pricing pressure and competition in the rapidly evolving health industry.

The stock's performance also reflects the broader sentiment towards companies like DXN that cater to niche health markets. Although the company is profitable, the share price does not yet reflect its full potential, perhaps due to market apprehension about its MLM structure and concerns regarding growth scalability. Moreover, as of recent data, the stock was trading at 0.615, well below the target price of 0.89, indicating a potential upside of over 44%, suggesting the stock might be undervalued by the market.

Posted by Good123 > 2 weeks ago | Report Abuse

History tends to repeat itself 😃

DXN Holdings Bhd (KL:DXN) is set to see an uptrend reversal after bouncing off the 21-day simple moving average line and testing the 66 sen immediate resistance level on Tuesday.

In a trading stocks note on Wednesday, the research house said that if a breakout occurs above this level, bullish momentum may propel the stock towards the 72 sen resistance, and then towards the next resistance level at 77 sen.

Posted by Good123 > 1 week ago | Report Abuse

Post-briefing update

Sales momentum in the majority of DXN’s operating regions have performed well in 1QFY25 but the surge in DXN’s core raw material costs will eventually weigh on group margins as product price adjustments may not fully offset higher production costs. We lower our FY25E-FY27E earnings estimate by 5%-8%. Rolling forward valuations to CY25E, our TP is lowered to MYR0.85 based on an unchanged 11x PER. Maintain BUY

Source: Maybank

Posted by Joel77 > 1 week ago | Report Abuse

counter not moving, haiz